Rhabdomyosarcoma staging

Rhabdomyosarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Rhabdomyosarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Rhabdomyosarcoma staging On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rhabdomyosarcoma staging All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rhabdomyosarcoma staging
CDC on Rhabdomyosarcoma staging
Rhabdomyosarcoma staging in the news
Blogs on Rhabdomyosarcoma staging
Directions to Hospitals Treating Rhabdomyosarcoma
Risk calculators and risk factors for Rhabdomyosarcoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

According to the Children's Oncology Group, there are four stages of rhabdomyosarcoma based on the location of tumor, size of tumor, involvement of lymph nodes, and metastasis.

Staging of rhabdomyosarcoma

According to the childrens oncology group, there are four stages of rhabdomyosarcoma based on the location of tumor, size of tumor, involvement of lymph nodes, and metastasis. The stages of rhabdomyosarcoma are shown in the table below:

Staging system for rhabdomyosarcoma

Stage	Description
Stage 1	Favorable site- orbit, eyelid, head and neck (excluding parameningeal), genitourinary (non-bladder, non-prostate); N0 or N1; M0
stage 2	Unfavorable site- urinary bladder, prostate, extremity, trunk, parameningeal, other; size <5 cm; N0; M0
stage 3	Unfavorable site- Bladder, prostate, extremity, trunk, parameningeal, other; size <5 cm; N1; M0
stage 3	Unfavorable site- Bladder, prostate, extremity, trunk, parameningeal, other; size >5 cm; N0 or N1; M0
stage 4	Favorable or unfavorable site- N0 or N1 ; M1

^{N0 = Regional nodes not clinically involved; N1 = Regional nodes clinically involved; M0 = No metastasis; M1 = distant metastasis}